1. Boskabadi H, Tavakol Afshari J, Ghayour-Mobarhan M, Maamouri G, Shakeri MT, Sahebkar A, et al. Association between serum interleukin-6 levels and severity of perinatal asphyxia. Asian Biomedicine 2010; 4: 79-85. [
DOI:10.2478/abm-2010-0009]
2. Boskabadi H, Zakerihamidi M, Sadeghian MH, Avan A, Ghayour-Mobarhan M, Ferns GA. Nucleated red blood cells count as a prognostic biomarker in predicting the complications of asphyxia in neonates. J Matern Fetal Neonatal Med 2017; 30: 2551-2556. [
DOI:10.1080/14767058.2016.1256988] [
PMID]
3. Boskabadi H, Ashrafzadeh F, Doosti H, Zakerihamidi M. Assessment of risk factors and prognosis in asphyxiated infants. Iran J Pediatr 2015; 25: e2006. [
DOI:10.5812/ijp.2006]
4. Costello AM, Manandhar DS. Perinatal asphyxia in less developed countries. Arch Dis Child Fetal Neonatal Ed 1994; 71: F1-F3. [
DOI:10.1136/fn.71.1.F1] [
PMID] [
PMCID]
5. Dixon G, Badawi N, Kurinczuk JJ, Keogh JM, Silburn SR, Zubrick SR, et al. Early developmental outcomes after newborn encephalopathy. Pediatrics 2002; 109: 26-33. [
DOI:10.1542/peds.109.1.26] [
PMID]
6. Utomo MT. Risk factors for birth asphyxia. Folia Medica Indonesiana 2011; 47: 211-214.
7. Naithani M, Simalti AK. Biochemical markers in perinatal asphyxia. J Nepal Paediatr Soc 2011; 31: 151-156. [
DOI:10.3126/jnps.v31i2.4155]
8. Boskabadi H, Maamouri G, Rezagholizade Omran F, Mafinejad S, Tara F, Rayman MP, et al. Effect of prenatal selenium supplementation on cord blood selenium and lipid profile. Pediatr Neonatol 2012; 53: 334-339. [
DOI:10.1016/j.pedneo.2012.08.008] [
PMID]
9. Boskabadi H, Maamouri G, Sadeghian MH, Ghayour-Mobarhan M, Heidarzade M, Shakeri MT, et al. Early diagnosis of perinatal asphyxia by nucleated red blood cell count: a case-control study. Arch Iran Med 2010; 13: 275-281.
10. Sävman K, Blennow M, Gustafson K, Tarkowski E, Hagberg H. Cytokine response in CSF after birth asphyxia. Pediatr Res 1998; 43: 746-751. [
DOI:10.1203/00006450-199806000-00006] [
PMID]
11. Boskabadi H, Omidian M, Tavallai S, Mohammadi S, Parizadeh M, Ghayour Mobarhan MG, et al. Serum Hsp70 antigen: early diagnosis marker in perinatal asphyxia. Iran J Pediatr 2015; 25: e381. [
DOI:10.5812/ijp.381]
12. Dammann O, Leviton A. Infection remote from the brain, neonatal white matter damage, and cerebral palsy in the preterm infant. Semin Pediatr Neurol 1998; 5: 190-201. [
DOI:10.1016/S1071-9091(98)80034-X]
13. Okazaki K, Kuboi T, Kusaka T, Kondo M, Kimura H. Pathophysiological roles of cytokines in the brain during perinatal asphyxia. Ann Pediatr Child Health 2015; 3: 1030-1039.
14. Oppenheim JJ. Cytokines: past, present, and future. Int J Hematol 2001; 74: 3-8. [
DOI:10.1007/BF02982543] [
PMID]
15. Dammann O, Leviton A. Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn. Pediatr Res 1997; 42: 1-8. [
DOI:10.1203/00006450-199707000-00001] [
PMID]
16. Dihné M, Block F. Focal ischemia induces transient expression of IL-6 in the substantia nigra pars reticulata. Brain Res 2001; 889: 165-173. [
DOI:10.1016/S0006-8993(00)03129-2]
17. Chiesa C, Pellegrini G, Panero A, De Luca T, Assumma M, Signore F, et al. Umbilical cord interleukin-6 levels are elevated in term neonates with perinatal asphyxia. Eur J Clin Invest 2003; 33: 352-358. [
DOI:10.1046/j.1365-2362.2003.01136.x] [
PMID]
18. Paliwal P, Varma M, Mulye S, Paliwal M, Shaikh M. Study of Neurological Marker in Perinatal Asphyxia and Its Correlation with Different Stages of Hypoxic Ischemic Encephalopathy. Int J Sci Study 2014; 2: 40-43.
19. Silveira Rde C, Procianoy RS. Levels of interleukin-6 and tumor necrosisfactor-alpha in the CSF of full-term newborns with hypoxic-ischemic encephalopathy. J Pediatr (Rio J) 2003; 79: 297-302. [
DOI:10.2223/JPED.1047]
20. Martin-Ancel A, Garcia-Alix A, Pascual-Salcedo D, Cabanas F, Valcarce M, Quero J. Interleukin-6 inthe CSF after perinatal asphyxia is related to early and late neurological manifestations. Pediatrics 1997; 100: 789-794. [
DOI:10.1542/peds.100.5.789] [
PMID]
21. Shang Y, Mu L, Guo X, Li Y, Wang L, Yang W, et al. Clinical significance of interleukin 6, tumor necrosis factor α and high sensitivity C reactive protein in neonates with hypoxic ischemic encephalopathy. Exp Ther Med 2014; 8: 1259-1262. [
DOI:10.3892/etm.2014.1869] [
PMID] [
PMCID]
22. Yi-hong Z,Lan-fen T,Dang A, Zan-cai S, Yu-li J. Relationship of interleukin-6 and insulin-like growth factor-1 serumlevels with brain damage in neonatal asphyxia. Journal of Guangdong Medical College 2004; 1: 007.
23. Boskabadi H, Maamouri G, TavakolAfshari J, Shakeri MT. Association between serum interleukin-1β levels and perinatal asphyxia. Iranian Journal of Neonatology 2010; 1: 24-29. [
DOI:10.2478/abm-2010-0009]
24. Oygür N, Sönmez Ö, Saka O, Yeǧin O. Predictive value of plasma and CSF tumour necrosis factor-α and interleukin-1β concentrations on outcome of full term infants with hypoxic-ischaemic encephalopathy. Arch Dis Child Fetal Neonatal Ed 1998; 79: F190-F193. [
DOI:10.1136/fn.79.3.F190] [
PMID] [
PMCID]
25. Boskabadi H, Maamouri G, Tavakkol Afshari J, Zakerihamidi M, Kalateh Molaee M, Bagheri F, et al. Combination of Serum interleukin-1β and 6 concentrations levels in thediagnosis perinatal asphyxia. Arch Iran Med 2015; 19: 312-316.
26. Fotopoulos S, Pavlou K, Skouteli H, Papassotiriou I, Lipsou N, Xanthou M. Early markers of brain damage in premature low-birth-weight neonates who suffered from perinatal asphyxia and/or infection. Biol Neonate 2001; 79: 213-218. [
DOI:10.1159/000047094] [
PMID]
27. Alsulaimani AA, Abuelsaad ASA, Mohamed NM. Inflammatory cytokines in neonatal hypoxic ischemic encephalopathy and their correlation with brain marker S100 protein: A case control study in Saudi Arabia. J Clin Cell Immunol 2015; 6: 2-9. [
DOI:10.4172/2155-9899.1000289]
28. Hagberg H, Gilland E, Bona E, Hanson LA, Hahn-Zoric M, Blennow M, et al. Enhanced expression of interleukin (IL)-1 and IL-6 messenger RNA and bioactive protein after hypoxia-ischemia in neonatal rats. Pediat Res 1996; 40: 603-609. [
DOI:10.1203/00006450-199610000-00015] [
PMID]
29. Selmaj KW, Farooq M, Norton WT, Raine CS, Brosnan CF. Proliferation of astrocytes in vitroin response to cytokines. A primary role for tumor necrosis factor. J Immunol 1990; 144: 129-135.
30. Kharazmi A, Nielsen H, Rechnitzer C, Bendtzen K. Interleukin 6 primes human neutrophil and monocyte oxidative burst response. Immunol Lett 1989; 21: 177-184. [
DOI:10.1016/0165-2478(89)90056-4]
31. Aly H, Khashaba MT, El-Ayouty M, El-Sayed O, Hasanein BM. IL-1β, IL-6 and TNF-α and outcomes of neonatal hypoxic ischemic encephalopathy. Brain Dev 2006; 28: 178-182. [
DOI:10.1016/j.braindev.2005.06.006] [
PMID]
32. Shalak LF, Laptook AR, Jafri HS, Ramilo O, Perlman JM. Clinical chorioamnionitis, elevated cytokines, and brain injury in term infants. Pediatrics 2002; 110: 673-680. [
DOI:10.1542/peds.110.4.673] [
PMID]
33. Suzuki S, Tanaka K, Suzuki N. Ambivalent aspects of interleukin-6 in cerebral ischemia: inflammatory versus neurotrophicaspects. J Cereb Blood Flow Metab 2009; 29: 464-479. [
DOI:10.1038/jcbfm.2008.141] [
PMID]
34. Jenkins DD, Rollins LG, Perkel JK, Wagner CL, Katikaneni LP, Bass WT, et al. Serum cytokines in a clinical trial of hypothermia for neonatal hypoxic-ischemic encephalopathy. J Cereb Blood Flow Metab 2012; 32: 1888-1896. [
DOI:10.1038/jcbfm.2012.83] [
PMID] [
PMCID]
35. Xing Z, Gauldie J, Cox G, Baumann H, Jordana M, Lei XF, et al. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest 1998; 101: 311-320. [
DOI:10.1172/JCI1368] [
PMID] [
PMCID]
36. Vila N, Castillo J, Dávalos A, Chamorro Á. Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke 2000; 31: 2325-2329. [
DOI:10.1161/01.STR.31.10.2325] [
PMID]
37. Nelson KB, Grether JK. Causes of cerebral palsy. Curr Opin Pediatr 1999; 11: 487-491. [
DOI:10.1097/00008480-199912000-00002] [
PMID]
38. Matsuda S, Wen TC, Morita F, Otsuka H, Igase K, Yoshimura H, et al. Interleukin-6 prevents ischemia-induced learning disability and neuronal and synaptic loss in gerbils. Neurosci Lett 1996; 204: 109-112. [
DOI:10.1016/0304-3940(96)12340-5]
39. Okazaki K, Nishida A, Kato M, Kozawa K, Uga N, Kimura H. Elevation of cytokine concentrations in asphyxiated neonates. Biol Neonate 2005; 89: 183-189. [
DOI:10.1159/000089180] [
PMID]
40. Yoon BH, Romero R, Park JS, Kim CJ, Kim SH, Choi JH, et al. Fetal exposure to an intra-amniotic inflammation and the development of cerebral palsy at the age of three years. Am J Obstet Gynecol 2000; 182: 675-681. [
DOI:10.1067/mob.2000.104207] [
PMID]
41. Tekgul H, Yalaz M, Kutukculer N, Ozbek S, Kose T, Akisu M, et al. Value of biochemical markers for outcome in term infants with asphyxia. Pediatr Neurol 2004; 31: 326-332. [
DOI:10.1016/j.pediatrneurol.2004.05.004] [
PMID]
42. Liu J, Feng ZC. Increased umbilical cord plasma interleukin-1β levels was correlated with adverse outcomes of neonatal hypoxic-ischemic encephalopathy. J Trop Pediatr 2010; 56: 178-182. [
DOI:10.1093/tropej/fmp098] [
PMID]
43. Oygur N, Sonmez O, Saka O, Yegin O. Predictive values of plasma and CSF TNF and interleukin 1 concentrations on outcome of full term infants with hypoxic ischemic encephalopathy. Arch Dis Child Fetal Neonatal Ed 1998; 79: F190-F193. [
DOI:10.1136/fn.79.3.F190] [
PMID] [
PMCID]
44. Martin D, Chinookoswong N, Miller G. The interleukin-1 receptor antagonist (rhIL-1ra) protects against cerebral infarction in a rat model of hypoxia-ischemia. Exp Neurol 1994; 130: 362-367. [
DOI:10.1006/exnr.1994.1215] [
PMID]